European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.5. Cardiovascular risks. Hyperhomocysteinaemia.
GUIDELINE: Based on the present data, it is not recommended to measure homocysteine levels.
D006801:Humans; D020138:Hyperhomocysteinemia / Q000209:etiology / Q000628:therapy*; D016030:Kidney Transplantation / Q000009:adverse effects*